BNP Paribas Exane Lowers Kimberly-Clark (NASDAQ:KMB) Price Target to $110.00

Kimberly-Clark (NASDAQ:KMB - Get Free Report) had its price target lowered by analysts at BNP Paribas Exane from $127.00 to $110.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a "neutral" rating on the stock. BNP Paribas Exane's price target suggests a potential upside of 0.73% from the stock's current price.

• Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction

Several other analysts also recently weighed in on the company. Cowen reiterated a "hold" rating on shares of Kimberly-Clark in a research report on Tuesday, November 4th. Wells Fargo & Company decreased their target price on shares of Kimberly-Clark from $129.00 to $110.00 and set an "equal weight" rating on the stock in a research note on Tuesday, November 4th. BNP Paribas reiterated a "neutral" rating and issued a $110.00 price target on shares of Kimberly-Clark in a research note on Monday. Evercore ISI restated an "in-line" rating and set a $120.00 price objective (down previously from $150.00) on shares of Kimberly-Clark in a research report on Tuesday, November 4th. Finally, TD Cowen dropped their target price on Kimberly-Clark from $135.00 to $130.00 and set a "hold" rating for the company in a research report on Friday, October 31st. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Kimberly-Clark presently has an average rating of "Hold" and an average target price of $126.00.

Get Our Latest Report on Kimberly-Clark

Kimberly-Clark Stock Performance

• 3 Safe and Steady Stocks for Any Market

KMB traded up $0.08 during trading hours on Monday, reaching $109.20. The company's stock had a trading volume of 2,147,708 shares, compared to its average volume of 2,889,261. Kimberly-Clark has a 52 week low of $99.22 and a 52 week high of $150.45. The firm has a market cap of $36.24 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 3.67 and a beta of 0.26. The company's 50-day moving average is $114.22 and its 200-day moving average is $125.68. The company has a debt-to-equity ratio of 4.61, a quick ratio of 0.56 and a current ratio of 0.77.

Kimberly-Clark (NASDAQ:KMB - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.37. Kimberly-Clark had a return on equity of 184.87% and a net margin of 12.87%.The company had revenue of $4.15 billion during the quarter, compared to the consensus estimate of $4.14 billion. During the same quarter last year, the firm earned $1.83 earnings per share. The company's revenue was up .1% on a year-over-year basis. On average, equities analysts forecast that Kimberly-Clark will post 7.5 EPS for the current year.

Institutional Trading of Kimberly-Clark

• Dividend King Kimberly-Clark Is a Good Buy in 2025

Several hedge funds have recently bought and sold shares of KMB. Investment Research & Advisory Group Inc. bought a new stake in Kimberly-Clark during the 2nd quarter valued at about $25,000. Cloud Capital Management LLC purchased a new position in shares of Kimberly-Clark during the third quarter worth approximately $25,000. True Wealth Design LLC raised its stake in shares of Kimberly-Clark by 177.6% during the third quarter. True Wealth Design LLC now owns 211 shares of the company's stock valued at $26,000 after acquiring an additional 135 shares in the last quarter. Princeton Global Asset Management LLC boosted its holdings in shares of Kimberly-Clark by 989.5% in the second quarter. Princeton Global Asset Management LLC now owns 207 shares of the company's stock valued at $27,000 after purchasing an additional 188 shares during the period. Finally, Winnow Wealth LLC purchased a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $27,000. Institutional investors and hedge funds own 76.29% of the company's stock.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Featured Articles

• Five stocks we like better than Kimberly-Clark
• CD Calculator: Certificate of Deposit Calculator
• Why Silver Beat Gold and the S&P in 2025—And What Comes Next
• What is the FTSE 100 index?
• 5 Healthcare Names to Watch as Sector Rotation Is in Full Swing
• Want to Profit on the Downtrend? Downtrends, Explained.
• NuScale's Shocking Q3 Was a Bullish Signal in Disguise

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kimberly-Clark Right Now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here